Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Melanoma 72Carcinoma, Renal Cell 26Kidney Neoplasms 22Skin Neoplasms 16Neoplasm Metastasis 14Leukemia, Myeloid, Acute 13Leukemia 13Breast Neoplasms 11Lymphoma 10Lymphoma, Non-Hodgkin 9Ovarian Neoplasms 8Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Pancreatic Neoplasms 5Neuroblastoma 5Myelodysplastic Syndromes 5Multiple Myeloma 5Lymphoma, Mantle-Cell 5Lung Neoplasms 5Congenital Abnormalities 5Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Liver Neoplasms 4Hodgkin Disease 4Gliosarcoma 4Glioblastoma 4Colorectal Neoplasms 4Central Nervous System Neoplasms 4Uterine Cervical Neoplasms 3

Interventions

Paclitaxel 56Carboplatin 56Bevacizumab 43Gemcitabine 20Taxes 19pembrolizumab 15Immunoglobulin G 13Disulfides 13Topotecan 12olaparib 11Cisplatin 11niraparib 9Cyclophosphamide 9liposomal doxorubicin 8Specimen Handling 7Docetaxel 6Biopsy 6mirvetuximab soravtansine 5Nivolumab 5Magnetic Resonance Spectroscopy 5Letrozole 5Hyperthermic Intraperitoneal Chemotherapy 5Drug Therapy 5Cytoreduction Surgical Procedures 5Albumin-Bound Paclitaxel 5rucaparib 4pazopanib 4oregovomab 4Surgical Procedures, Operative 4Neoadjuvant Therapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fallopian Tube Neoplasms × aldesleukin × Clear all
NCT00652899 2017-12-28

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
14 enrolled 9 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡